4-carboxyphenylglyoxal has been researched along with Paraganglioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balachander, S; Bowen, B; Clifton-Bligh, R; Dahia, PLM; Fishbein, L; Flynn, A; Frysak, Z; Gill, AJ; Grimmond, S; Hicks, RJ; Hogg, A; Martelotto, L; Miller, JA; Pacak, K; Pattison, A; Rossello, FJ; Tischler, AS; Tothill, RW; Zethoven, M | 1 |
| Cao, J; Cha, L; Guo, W; Lei, J; Qiu, F; Qu, T; Sun, C; Tian, L; Zhou, B | 1 |
2 other study(ies) available for 4-carboxyphenylglyoxal and Paraganglioma
| Article | Year |
|---|---|
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
Topics: Adrenal Gland Neoplasms; Humans; Paraganglioma; Pheochromocytoma; Succinate Dehydrogenase; Tumor Microenvironment | 2022 |
Clinicopathological characteristics of pheochromocytoma/paraganglioma and screening of prognostic markers.
Topics: Adrenal Gland Neoplasms; Humans; Paraganglioma; Pheochromocytoma; Prognosis | 2023 |